Pyrrolidine aryl-ether as NK3 receptor antagonists

Details for Australian Patent Application No. 2008285718 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Wu, Xihan; Knust, Henner; Nettekoven, Matthias; Kawasaki, Kenichi; Jablonski, Philippe; Limberg, Anja; Riemer, Claus; Ratni, Hasane

Agent Spruson & Ferguson

Pub. Number AU-A-2008285718

PCT Pub. Number WO2009/019163

Priority 07113942.2 07.08.07 EP

Filing date 29 July 2008

Wipo publication date 12 February 2009

International Classifications

C07D 401/08 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

25 February 2010 PCT application entered the National Phase

  PCT publication WO2009/019163 Priority application(s): WO2009/019163

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008285722-6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis

2008285697-New BNP(1-32) epitope and antibodies directed against said epitope